In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.

OBJECTIVES:To investigate the in  vitro activity of olorofim (F901318), a novel broad-spectrum antifungal agent, against 150 strains belonging to 16 different cryptic species of Aspergillus by EUCAST and CLSI methodologies.

Source: The Aspergillus Website - updates - March 25, 2019 Category: Respiratory Medicine Authors: GAtherton Source Type: news